U.S. House · 117th Congress · H.R. 8641
Orphan Drug COVID–19 Mitigation Act of 2022
To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic for the development of orphan drugs, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Josh GottheimerD-NJ-5
- Introduced
- August 2, 2022, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (3)
2 Democrats, 1 Republican. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Don BaconR-NE-2
- Madeleine DeanD-PA-4
Signed on later
- Kurt SchraderD-OR-5October 21, 2022